NorthWest Biotherapeutics Inc (NWBO)

[j e d]

this is reverse p-hacking, and why endpoints are determined before data is unblinded. if this component were integrated into an endpoint, that would be an issue—but the ECA and endpoints were vetted thoroughly before unblinding. with any trial, you can scrounge after the fact and find some subcategory or factor that looks to be causal/SS, but it’s moot. I know it didn’t turn out the way you wanted and the whole thing seems unfair to you, but it is what it is.